tradingkey.logo

Avanos Medical Inc

AVNS
查看詳細走勢圖
11.410USD
+0.010+0.09%
收盤 12/26, 16:00美東報價延遲15分鐘
529.62M總市值
虧損本益比TTM

Avanos Medical Inc

11.410
+0.010+0.09%
盤中分時
1分
30分
1小時
日k
週k
月k
日k

今天

+0.09%

5天

-2.23%

1月

-3.63%

6月

-6.55%

今年開始到現在

-28.33%

1年

-28.33%

查看詳細走勢圖

TradingKey Avanos Medical Inc股票評分

單位: USD 更新時間: 2025-12-26

操作建議

Avanos Medical Inc當前公司基本面數據相對非常健康,增長潛力很大。當前估值合理,在醫療設備與耗材行業排名64/207位。機構持股佔比非常高,近一個月多位分析師給出公司評級為持有。最高目標價14.00。中期看,股價處於平穩狀態。近一個月,市場表現一般,但公司基本面和技術面得分較高。目前股價在壓力位和支撐位之間,可以做區間波段操作。

Avanos Medical Inc評分

相關信息

行業排名
64 / 207
全市場排名
175 / 4563
所屬行業
醫療設備與耗材

壓力支撐

由於公司未披露,未能獲取相關數據

多維評測

本期評分
上期評分

分析師目標

基於 1 分析師
持有
評級
14.000
目標均價
+13.73%
漲幅空間
數據免責聲明:分析師評級與目標價由LSEG提供,僅供參考,不應當作投資建議

Avanos Medical Inc亮點

亮點風險
Avanos Medical, Inc. is a medical technology company focused on delivering medical device solutions. It offers healthcare needs, such as providing nutrition to patients from hospital to home and reducing the use of opioids while helping patients move from surgery to recovery. Specialty Nutrition Systems portfolio of products includes enteral feeding, which consist of MIC-KEY enteral feeding tubes and Corpak patient feeding solutions, and Neonate solutions feeding products consist of NeoMed neonatal and pediatric feeding solutions. It also includes TKO, an anti-reflux needleless connector technology, which is used in Neonatal and Pediatric Intensive Care Units. The Pain Management and Recovery portfolio of products includes surgical pain and recovery products such as ON-Q and ambIT surgical pain pumps and Game Ready cold and compression therapy systems and Radiofrequency Ablation solutions, which provide invasive pain relief therapies, such as COOLIEF, Trident and ESSENTEC RFA products.
估值合理
公司最新PE估值-1.12,處於3年歷史合理位
機構加倉
最新機構持股44.88M股,環比增加0.01%
PRFDX持倉
明星投資者PRFDX持倉,最新持倉13.39K股
活躍度增加
近期活躍度增加,過去20天平均換手率1.26

Avanos Medical Inc新聞

即將為您帶來更多新聞,敬請期待。 。 。

財務指標

每股收益

由於公司未披露,未能獲取相關數據

營業總收入

由於公司未披露,未能獲取相關數據

Avanos Medical Inc簡介

Avanos Medical, Inc. is a medical technology company focused on delivering medical device solutions. It offers healthcare needs, such as providing nutrition to patients from hospital to home and reducing the use of opioids while helping patients move from surgery to recovery. Specialty Nutrition Systems portfolio of products includes enteral feeding, which consist of MIC-KEY enteral feeding tubes and Corpak patient feeding solutions, and Neonate solutions feeding products consist of NeoMed neonatal and pediatric feeding solutions. It also includes TKO, an anti-reflux needleless connector technology, which is used in Neonatal and Pediatric Intensive Care Units. The Pain Management and Recovery portfolio of products includes surgical pain and recovery products such as ON-Q and ambIT surgical pain pumps and Game Ready cold and compression therapy systems and Radiofrequency Ablation solutions, which provide invasive pain relief therapies, such as COOLIEF, Trident and ESSENTEC RFA products.
公司代碼AVNS
公司Avanos Medical Inc
CEOPacitti (David)
網址https://avanos.com/

常見問題

Avanos Medical Inc(AVNS)的當前股價是多少?

Avanos Medical Inc(AVNS)的當前股價是 11.410。

Avanos Medical Inc 的股票代碼是什麼?

Avanos Medical Inc的股票代碼是AVNS。

Avanos Medical Inc股票的52週最高點是多少?

Avanos Medical Inc股票的52週最高點是17.690。

Avanos Medical Inc股票的52週最低點是多少?

Avanos Medical Inc股票的52週最低點是9.303。

Avanos Medical Inc的市值是多少?

Avanos Medical Inc的市值是529.62M。

Avanos Medical Inc的淨利潤是多少?

Avanos Medical Inc的淨利潤為-392.10M。

現在Avanos Medical Inc(AVNS)的股票是買入、持有還是賣出?

根據分析師評級,Avanos Medical Inc(AVNS)的總體評級為持有,目標價格為14.000。

Avanos Medical Inc(AVNS)股票的每股收益(EPS TTM)是多少

Avanos Medical Inc(AVNS)股票的每股收益(EPS TTM)是-10.183。
KeyAI